Prognostic implication of NQO1 overexpression in hepatocellular carcinoma
Authors:
- 1 November 2017
- journal article
- Published by Elsevier in Human Pathology
- Vol. 69, 31-37
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in AsiansGenetics and Molecular Research, 2012
- Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal CarcinomaThe Annals of Thoracic Surgery, 2010
- Hepatocellular carcinoma in the Asia pacific regionJournal of Gastroenterology and Hepatology, 2009
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- NRH:Quinone Oxidoreductase 2 and NAD(P)H:Quinone Oxidoreductase 1 Protect Tumor Suppressor p53 against 20S Proteasomal Degradation Leading to Stabilization and Activation of p53Cancer Research, 2007
- NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide ScavengerMolecular Pharmacology, 2004
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Genotype-phenotype relationships in studies of a polymorphism in NAD(P)HPharmacogenetics, 1999
- Purified NAD(P)H‐quinone oxidoreductase enhances the mutagenicity of dinitropyrenes in vitroJournal of Biochemical Toxicology, 1991
- Induction of dna damage by menadione (2-methyl-1,4-naphthoquinone) in primary cultures of rat hepatocytesBiochemical Pharmacology, 1984